AU2001290694A1 - Gene and sequence variation associated with lipid disorder - Google Patents

Gene and sequence variation associated with lipid disorder

Info

Publication number
AU2001290694A1
AU2001290694A1 AU2001290694A AU9069401A AU2001290694A1 AU 2001290694 A1 AU2001290694 A1 AU 2001290694A1 AU 2001290694 A AU2001290694 A AU 2001290694A AU 9069401 A AU9069401 A AU 9069401A AU 2001290694 A1 AU2001290694 A1 AU 2001290694A1
Authority
AU
Australia
Prior art keywords
gene
sequence variation
variation associated
lipid disorder
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001290694A
Inventor
Jackie S. Bodnar
Lawrence W. Castellani
Aurobindo Chatterjee
Pieter De Jong
Aldons J. Lusis
Jeff Ohmen
David Ross
Sherrie Tafuri
Chenyan Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU2001290694A1 publication Critical patent/AU2001290694A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001290694A 2000-09-08 2001-09-07 Gene and sequence variation associated with lipid disorder Abandoned AU2001290694A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23132200P 2000-09-08 2000-09-08
US60/231,322 2000-09-08
PCT/US2001/028181 WO2002020847A2 (en) 2000-09-08 2001-09-07 Gene and sequence variation associated with lipid disorder

Publications (1)

Publication Number Publication Date
AU2001290694A1 true AU2001290694A1 (en) 2002-03-22

Family

ID=22868732

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001288940A Abandoned AU2001288940A1 (en) 2000-09-08 2001-09-07 Gene and sequence variation associated with cancer
AU2001290694A Abandoned AU2001290694A1 (en) 2000-09-08 2001-09-07 Gene and sequence variation associated with lipid disorder

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001288940A Abandoned AU2001288940A1 (en) 2000-09-08 2001-09-07 Gene and sequence variation associated with cancer

Country Status (3)

Country Link
US (1) US20030054418A1 (en)
AU (2) AU2001288940A1 (en)
WO (2) WO2002020847A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5414958B2 (en) * 2000-06-05 2014-02-12 ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨーク Identification of human bone marrow-derived endothelial progenitor cells and use of human bone marrow-derived endothelial progenitor cells to improve the function of cardiomyocytes after ischemic injury
US20030199464A1 (en) * 2002-04-23 2003-10-23 Silviu Itescu Regeneration of endogenous myocardial tissue by induction of neovascularization
KR101744169B1 (en) 2013-08-12 2017-06-09 사회복지법인 삼성생명공익재단 Biomarkers for Diagnosing a Tumor Disorder and Uses Thereof
WO2021173892A1 (en) * 2020-02-28 2021-09-02 Academia Sinica Animal models of lipid metabolism and methods of treating hyperlipidemia or hyperlipidemia-related diseases

Also Published As

Publication number Publication date
WO2002020848A2 (en) 2002-03-14
WO2002020848A3 (en) 2003-08-07
AU2001288940A1 (en) 2002-03-22
WO2002020847A3 (en) 2003-07-31
WO2002020847A2 (en) 2002-03-14
US20030054418A1 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
AU2001288754A1 (en) Multiple advertising
AU2001278415A1 (en) Alpha-amylase mutants with altered stability
WO2002017157A8 (en) Marketing systems and methods
AU2001253618A1 (en) Flavopiridol drug combinations and methods with reduced side effects
AU2001215798A1 (en) Click-to-add, jot-it-down, and add banner
AU2001232841A1 (en) Bore-resistant digital goods configuration and distribution methods and arrangements
AUPR009000A0 (en) Intelligent courseware developement and delivery environment
AU2001281636A1 (en) Advertising
AU2001267171A1 (en) Modified xylanases exhibiting increased thermophilicity and alkalophilicity
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
AU2001242625A1 (en) Gene sequence
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001264852A1 (en) Lactobacillusbeta -glucuronidase and dna encoding the same
AUPQ600800A0 (en) User-targeted information and advertising
AU2001264247A1 (en) GASC1 gene
AU2001270478A1 (en) Gene expression in biological conditions
AU2001290694A1 (en) Gene and sequence variation associated with lipid disorder
AU2001272373A1 (en) Cgtase and dna sequence encoding same
AU2001256143A1 (en) Chondrocyte cultures and fractions therefrom
AU2001247444A1 (en) Erbeta-mediated gene expression
AU2001291194A1 (en) Multiple region convolver with tapering
AU2001285743A1 (en) Adipose-related gene
AU1894601A (en) Novel gene and use thereof
AU2002233285A1 (en) Interleukin-1 related gene and protein
AU2002256556A1 (en) Sea-trosy and related methods